Oppenheimer Asset Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-69,083
Closed -$6.32M 1129
2023
Q2
$6.32M Sell
69,083
-1,195
-2% -$98K 0.09% 248
2023
Q1
$5.17M Buy
70,278
+4,730
+7% +$409K 0.08% 273
2022
Q4
$5.48M Sell
65,548
-7,278
-10% -$656K 0.09% 242
2022
Q3
$7.05M Sell
72,826
-2,343
-3% -$279K 0.12% 209
2022
Q2
$7.9M Sell
75,169
-3,430
-4% -$438K 0.13% 186
2022
Q1
$13.5M Buy
78,599
+3,030
+4% +$453K 0.19% 129
2021
Q4
$12.2M Buy
75,569
+24,038
+47% +$3.86M 0.16% 152
2021
Q3
$7.68M Buy
51,531
+469
+0.9% +$97.5K 0.11% 218
2021
Q2
$12.5M Buy
51,062
+5,906
+13% +$1.55M 0.18% 131
2021
Q1
$12M Buy
45,156
+6,085
+16% +$1.72M 0.19% 132
2020
Q4
$11.5M Buy
39,071
+639
+2% +$164K 0.19% 129
2020
Q3
$9.09M Buy
38,432
+1,293
+3% +$294K 0.18% 148
2020
Q2
$7.37M Buy
37,139
+2,540
+7% +$474K 0.15% 163
2020
Q1
$6.35M Buy
34,599
+413
+1% +$73.5K 0.16% 157
2019
Q4
$5.71M Buy
34,186
+416
+1% +$61.9K 0.12% 203
2019
Q3
$4.42M Sell
33,770
-599
-2% -$78K 0.1% 243
2019
Q2
$4.17M Buy
+34,369
New +$4.08M 0.09% 257

Other funds holding AMED

Oppenheimer Asset Management's AMED Position: Q3 2023 in Review

Oppenheimer Asset Management sold out of Amedisys (AMED) in Q3 2023, closing a stake of 69,083 shares — an estimated $6.32M sold.

Oppenheimer Asset Management first reported a position in AMED in Q2 2019 and held it in 17 quarters. The position peaked at $13.5M in Q1 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Oppenheimer Asset Management reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Oppenheimer Asset Management sold 69,083 Amedisys shares in Q3 2023, an estimated $6.32M.
  • Oppenheimer Asset Management first reported a position in Amedisys in Q2 2019 and held it in 17 quarters.
  • Oppenheimer Asset Management's Amedisys position peaked at $13.5M in Q1 2022.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Oppenheimer Asset Management's 13F filing for Q3 2023, filed 8 Nov 2023.